GC
CGNT

Guggenheim Capital’s Cogentix Medical, Inc. CGNT Stock Holding History

Guggenheim Capital’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,649
Closed -$56K – 2786
2018
Q1 		$56K Buy
14,649
+89
+0.6% +$278 ﹤0.01% 2701
2017
Q4 		$46K Sell
14,560
-2,524
-15% -$7.27K ﹤0.01% 2637
2017
Q3 		$44K Buy
17,084
+116
+0.7% +$254 ﹤0.01% 2706
2017
Q2 		$30K Hold
16,968
– – ﹤0.01% 2763
2017
Q1 		$31K Buy
+16,968
New +$33.5K ﹤0.01% 2755

Guggenheim Capital's CGNT Position: Q2 2018 in Review

Guggenheim Capital sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 14,649 shares — an estimated $56K sold.

Guggenheim Capital first reported a position in CGNT in Q1 2017 and held it in 5 quarters. The position peaked at $56K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

  • Guggenheim Capital reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 14,649 Cogentix Medical, Inc. shares in Q2 2018, an estimated $56K.
  • Guggenheim Capital first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 5 quarters.
  • Guggenheim Capital's Cogentix Medical, Inc. position peaked at $56K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.